New Rochester
and Syracuse locations will expand
the Company's retail footprint to six dispensaries in
New York and 148
nationwide
Existing Curaleaf Plattsburgh and Curaleaf
Forest Hills stores will now offer co-located medical and adult-use
sales
STAMFORD,
Conn., July 25, 2024 /PRNewswire/ -- Curaleaf
Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the
"Company"), a leading international provider of consumer cannabis
products, today announced it will open two new medical
dispensaries, and will begin co-located adult-use sales at two
existing medical dispensaries in New
York. Curaleaf Rochester, located at 532 Chili Ave,
Rochester, NY 14611, will open
later today, July 25 and Curaleaf
Syracuse, located at 4141 South Salina St, Syracuse, NY 13205, will open in the coming
weeks, pending regulatory approval. On July
20, co-located adult-use sales began at the existing medical
store, Curaleaf Plattsburgh, and Curaleaf Forest Hills will begin
co-located adult-use sales on July
26. This expansion will increase the Company's retail
footprint in the Empire State to six total, with three co-located
adult-use and medical locations, and three medical-only
locations.
In celebration of the new store openings,
Curaleaf Rochester will host a grand opening event on Friday, July 26, featuring live local music, food
trucks, and prizes. Curaleaf Syracuse will host its grand opening
at a later date, pending regulatory approval. Each new medical
dispensary is staffed with a team of three full-time pharmacists to
assist patients in exploring the Company's expansive collection of
brands and products, including Grassroots indoor-grown flower,
Select's full line up of vape and edible products including the new
Select Fruit STIQ All-In-One Vape, JAMS edibles, B NOBLE, and
New York's best-selling all-in-one
two gram vape, Select BRIQ.
Adult-use consumers and medical patients can
maximize their retail experience by enrolling in Curaleaf Rewards
to earn special offers and discounts. During each visit, Curaleaf's
team of knowledgeable staff members will be available to provide
assistance, answer questions, and guide consumers through the wide
world of adult-use cannabis.
"We thank the Office of Cannabis Management for
approving us to expand our operations to ensure even more
New York patients and customers
have access to licensed, tested cannabis across the state," said
Matt Darin, CEO of Curaleaf. "From
Rochester to Forest Hills, our
team members are eager to welcome the newest members of our
cannabis community while continuing to provide medical patients
with the high-quality service and products they deserve. This is an
exciting step forward for our retail operations in New York, which we consider to be a key
founding state for the Curaleaf brand."
Curaleaf remains steadfast in its commitment to
uplifting the medical patients and adult-use consumers of
New York through health, wellness,
and community. At each adult-use location, Curaleaf will continue
to prioritize medical patients with access to dedicated staff
members, industry-leading product offerings, and other amenities
designed to provide a premier retail experience. For more
information on Curaleaf's locations, patient resources, delivery
program, and products in New York,
please visit https://curaleaf.com/dispensary/new-york.
About Curaleaf Holdings
Curaleaf
Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading
international provider of consumer products in cannabis with a
mission to enhance lives by cultivating, sharing and celebrating
the power of the plant. As a high-growth cannabis company known for
quality, expertise and reliability, the Company and its brands,
including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof
provide industry-leading service, product selection and
accessibility across the medical and adult-use markets. Curaleaf
International is the largest vertically integrated cannabis company
in Europe with a unique supply and
distribution network throughout the European market, bringing
together pioneering science and research with cutting-edge
cultivation, extraction, and production. Curaleaf is listed on the
Toronto Stock Exchange under the symbol CURA and trades on the
OTCQX market under the symbol CURLF. For more information, please
visit https://ir.curaleaf.com.
Forward Looking Statements:
This media
advisory contains forward-looking statements and forward-looking
information within the meaning of applicable securities laws. These
statements relate to future events or future performance. All
statements other than statements of historical fact may be
forward–looking statements or information. Generally,
forward-looking statements and information may be identified by the
use of forward-looking terminology such as "plans", "expects" or
"proposed", "is expected", "intends", "anticipates", or "believes",
or variations of such words and phrases, or by the use of words or
phrases which state that certain actions, events or results may,
could, would, or might occur or be achieved. More particularly and
without limitation, this news release contains forward-looking
statements and information concerning the Company's expansion in
New York. Such forward-looking
statements and information reflect management's current beliefs and
are based on assumptions made by and information currently
available to the company with respect to the matter described in
this new release. Forward-looking statements involve risks and
uncertainties, which are based on current expectations as of the
date of this release and subject to known and unknown risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. Additional
information about these assumptions and uncertainties is contained
under "Risk Factors and Uncertainties" in the Company's latest
annual information form filed on March 6,
2024, which is available under the Company's SEDAR profile
at http://www.sedar.com, and in other filings that the Company has
made and may make with applicable securities authorities in the
future. Forward-looking statements contained herein are made only
as to the date of this press release and we undertake no obligation
to update or revise any forward-looking statements whether as a
result of new information, future events or otherwise, except as
required by law. We caution investors not to place considerable
reliance on the forward-looking statements contained in this press
release. The Toronto Stock Exchange has not reviewed, approved or
disapproved the content of this news release.
Contacts:
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment
Officer
IR@curaleaf.com
Media Contact:
Curaleaf Holdings, Inc.
Jordon Rahmil, VP Corporate Communications
media@curaleaf.com
View original
content:https://www.prnewswire.com/news-releases/curaleaf-announces-new-york-retail-expansion-with-two-new-medical-dispensaries-and-adult-use-sales-at-two-existing-stores-302206333.html
SOURCE Curaleaf Holdings, Inc.